Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSyndax Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Syndax Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $72.79M. Net result −$49.36M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $72.79M. Running result $72.79M. Collaboration Revenue: $18.09M. Product: $54.7M.
  • Cost of revenue: $0. Running result $72.79M.
  • Gross profit: $72.79M. Running result $72.79M.
  • Operating costs: −$112.78M. Running result −$40M.
  • Operating income: −$40M. Running result −$40M.
  • Other expense: −$9.37M. Running result −$49.36M.
  • Pre-tax loss: −$49.36M. Running result −$49.36M.
  • Income tax benefit: $0. Running result −$49.36M.
  • Net loss: −$49.36M. Running result −$49.36M.